Association of serum vitamin D levels with clinical spectrum of central serous chorioretinopathy patients of Indian origin.

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as an observational study.

To determine serum vitamin D levels in various clinical profiles of central serous chorioretinopathy and their effect on its pathophysiology in Indian population.

Why It Was Studied

Vitamin D, a fat-soluble prohormone has been implicated in various ophthalmological diseases such as ocular inflammation, glaucoma, diabetic retinopathy and ocular angiogenesis.

Who Took Part

The abstract describes 42 patients taking part.

By PubMed's age tags, the people studied were adults.

Case control observational study METHODS: Study included 42 patients (group P) of central serous chorioretinopathy (CSCR) diagnosed with optic coherence tomography (OCT), fundus fluorescein angiography (FFA) which were further sub-grouped into acute(P1), chronic (P2) and recurrent (P3).

A total of 44 age & sex-matched healthy control subjects (group C) were also included.

How the Study Was Run

The vitamin D levels of both groups were examined and analyzed.

What Was Measured

PubMed files the paper under topics including Central Serous Chorioretinopathy, Fluorescein Angiography, Photochemotherapy, Photosensitizing Agents, Tomography, Optical Coherence, Vitamin D and Case-Control Studies.

The authors tagged it with the keywords Indian population, Optical coherence tomography and Serum vitamin D.

What This Means in Plain Language

This is an observational study of Vitamin D, K2, Magnesium and Zinc in 42 patients.

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2023 (Photodiagnosis and photodynamic therapy), a journal based in Netherlands.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.